Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
622 | 10390 | 33.8 | 66% |
Classes in level above (level 4) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
0 | 3633673 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//MED |
Classes in level below (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | GOUT | Author keyword | 1124 | 69% | 9% | 968 |
2 | HYPERURICEMIA | Author keyword | 458 | 60% | 5% | 498 |
3 | URIC ACID | Author keyword | 368 | 31% | 10% | 996 |
4 | SERUM URIC ACID | Author keyword | 198 | 73% | 1% | 153 |
5 | FEBUXOSTAT | Author keyword | 183 | 80% | 1% | 113 |
6 | ALDEHYDE OXIDASE | Author keyword | 143 | 66% | 1% | 134 |
7 | TOPHI | Author keyword | 115 | 89% | 0% | 51 |
8 | PSEUDOGOUT | Author keyword | 112 | 75% | 1% | 81 |
9 | RENAL HYPOURICEMIA | Author keyword | 102 | 95% | 0% | 35 |
10 | ALLOPURINOL | Author keyword | 100 | 30% | 3% | 285 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | GOUT | 1124 | 69% | 9% | 968 | Search GOUT | Search GOUT |
2 | HYPERURICEMIA | 458 | 60% | 5% | 498 | Search HYPERURICEMIA | Search HYPERURICEMIA |
3 | URIC ACID | 368 | 31% | 10% | 996 | Search URIC+ACID | Search URIC+ACID |
4 | SERUM URIC ACID | 198 | 73% | 1% | 153 | Search SERUM+URIC+ACID | Search SERUM+URIC+ACID |
5 | FEBUXOSTAT | 183 | 80% | 1% | 113 | Search FEBUXOSTAT | Search FEBUXOSTAT |
6 | ALDEHYDE OXIDASE | 143 | 66% | 1% | 134 | Search ALDEHYDE+OXIDASE | Search ALDEHYDE+OXIDASE |
7 | TOPHI | 115 | 89% | 0% | 51 | Search TOPHI | Search TOPHI |
8 | PSEUDOGOUT | 112 | 75% | 1% | 81 | Search PSEUDOGOUT | Search PSEUDOGOUT |
9 | RENAL HYPOURICEMIA | 102 | 95% | 0% | 35 | Search RENAL+HYPOURICEMIA | Search RENAL+HYPOURICEMIA |
10 | ALLOPURINOL | 100 | 30% | 3% | 285 | Search ALLOPURINOL | Search ALLOPURINOL |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HYPERURICEMIA | 1280 | 70% | 10% | 1076 |
2 | GOUT | 421 | 55% | 5% | 521 |
3 | SERUM URIC ACID | 402 | 53% | 5% | 535 |
4 | DIMETHYL SULFOXIDE REDUCTASE | 334 | 70% | 3% | 274 |
5 | DMSO REDUCTASE | 317 | 90% | 1% | 137 |
6 | SERUM URATE | 270 | 85% | 1% | 144 |
7 | TOPHACEOUS GOUT | 218 | 77% | 1% | 147 |
8 | SULFITE OXIDASE | 193 | 57% | 2% | 228 |
9 | ALLOPURINOL | 179 | 33% | 4% | 451 |
10 | MOLYBDENUM COFACTOR | 178 | 58% | 2% | 203 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Uric acid and cardiovascular risk | 2008 | 612 | 114 | 75% |
The Mononuclear Molybdenum Enzymes | 2014 | 35 | 646 | 72% |
The mononuclear molybdenum enzymes | 1996 | 1135 | 339 | 76% |
Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative | 2014 | 21 | 88 | 90% |
Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? | 2003 | 506 | 76 | 87% |
The role of uric acid in the pathogenesis of human cardiovascular disease | 2013 | 49 | 123 | 85% |
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR standing committee for international clinical studies including therapeutics (ESCISIT) | 2006 | 427 | 71 | 69% |
The Molecular Physiology of Uric Acid Homeostasis | 2015 | 4 | 137 | 55% |
A Review of Uric Acid, Crystal Deposition Disease, and Gout | 2015 | 2 | 45 | 98% |
Evolution of management of gout: a comparison of recent guidelines | 2015 | 2 | 31 | 97% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MET BIOL | 13 | 34% | 0.3% | 32 |
2 | INTEGRAT PHYSIOL BIONANO MED | 11 | 40% | 0.2% | 22 |
3 | UNIT ANALYT PROBES PROT BIOTECHNOLEDUC MINIST | 8 | 100% | 0.0% | 5 |
4 | KIDNEY HYPERTENS | 6 | 20% | 0.3% | 29 |
5 | BIOMED ANALYT SCI | 6 | 71% | 0.0% | 5 |
6 | BIOANALYT CHEM DIAGNOST GRP | 6 | 100% | 0.0% | 4 |
7 | IWO TO AIR BASE GRP | 6 | 100% | 0.0% | 4 |
8 | SECC RHEUMATOL | 6 | 100% | 0.0% | 4 |
9 | BIOST S | 5 | 42% | 0.1% | 10 |
10 | CHIM BACTERIENNE | 5 | 10% | 0.5% | 48 |
Related classes at same level (level 3) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000003097 | HYPOPHOSPHATASIA//ALKALINE PHOSPHATASE//TISSUE NONSPECIFIC ALKALINE PHOSPHATASE |
2 | 0.0000002068 | NM23//RIBONUCLEOTIDE REDUCTASE//DEOXYCYTIDINE KINASE |
3 | 0.0000001867 | NITROGEN FIXATION//CYANOBACTERIA//MICROCYSTINS |
4 | 0.0000001724 | TOXIC EPIDERMAL NECROLYSIS//STEVENS JOHNSON SYNDROME//DRUG HYPERSENSITIVITY |
5 | 0.0000001674 | RHEUMATOID ARTHRITIS//RHEUMATOLOGY//RHEUMATOL |
6 | 0.0000001554 | PHENYLKETONURIA//TETRAHYDROBIOPTERIN//NEOPTERIN |
7 | 0.0000001486 | PHOTOSYSTEM II//PHOTOSYNTHESIS RESEARCH//PHOTOSYSTEM I |
8 | 0.0000001432 | UROLITHIASIS//CALCIUM OXALATE//KIDNEY CALCULI |
9 | 0.0000001399 | ACETIC ACID BACTERIA//PYRROLOQUINOLINE QUINONE//ASYMMETRIC REDUCTION |
10 | 0.0000001393 | CHRONIC GRANULOMATOUS DISEASE//RAMADAN//RAMADAN FASTING |